Substance Use Disorder
AHA today voiced support for several proposed changes to the federal regulation governing the confidentiality of substance use disorder patients’ records that would reduce the burden and delay associated with accessing certain recovery services and add declared disasters to the list of exceptions.
The AHA recognizes that SAMHSA is statutorily constrained in making structural amendments to the regulations under 42 CFR Part 2; however, because the proposed rule would not change the basic framework of Part 2, which significantly impedes the robust sharing of patient information necessary for…
The Drug Enforcement Administration yesterday published a proposed rule implementing provisions of the Substance Use-Disorder Prevention that Promotes Opioid Recovery Treatment for Patients and Communities Act that require the agency to limit production quotas for five opioid substances vulnerable…
The National Institutes of Health yesterday awarded $945 million in fiscal year 2019 funding under its Helping to End Addiction Long-term Initiative for research projects to improve treatments for chronic pain, curb opioid use disorder and overdose rates, and support long-term recovery from opioid…
The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders.
According to a committee summary, the draft bill would provide $93.4 billion in discretionary funding for the Department of Health and Human Services, an increase of $2.9 billion over FY 2019.
The Alliance for Addiction Payment Reform, of which the AHA is a member, is partnering with health care providers and payers to test an alternative payment model for addiction treatment and recovery in Connecticut, Kentucky, North Carolina, Tennessee, Texas and Washington, D.C.
The Substance Abuse and Mental Health Services Administration today released a proposed rule that would amend federal regulations regarding disclosure of patient information for individuals seeking treatment for substance use disorders.
The number of U.S. residents misusing pain relievers fell by 11% in 2018, to about 9.9 million, according to the latest National Survey on Drug Use and Health from the Substance Abuse and Mental Health Services Administration.
The U.S. Preventative Services Task Force yesterday released for comment a draft recommendation that primary care clinicians screen all adults for illicit drug use, including nonmedical prescription drug use.